Kemwell adds freeze-drying tech at Bangalore biologics plant

- Last updated on GMT

Kemwell adds freeze-drying tech

Related tags: Boehringer ingelheim

Kemwell has added commercial-scale lyophilisation capacity at its plant in Bangalore, India citing growing demand from the sterile injectables sector.

The technology has capacity for 4,000 50ml vials or 29,000 2ml vials, cleaning in place (CIP) and sterilization in place (SIP) capabilities and means the contract manufacturing organisation (CMO) can provide freeze-drying from preclinical research through to commercial scale.

Managing director Anurag Bagaria said: “The outsourcing of services in bio/pharmaceutical industry is growing and Kemwell will continue to invest into technologies to support our customers’ needs​.” 

Kemwell set up the facility in Bangalore, India in 2008 with help from German privately-owned drugmaker Boehringer Ingelheim, which assisted with "technical design of the plant​" according to spokeswoman Karan Bagaria who told Outsourcing-pharma.com about the expansion.

This site already features a BI HEX high expression system, which is designed to accelerate the development of high-titer processes for producing biologics from Chinese hamster ovary (CHO) cells.

Contract

Last year Kemwell signed its first biomanufacturing contract for the plant when it was hired by an unnamed mid-size European biopharma company.

At the time Bagaria told Outsourcing-pharma.com that: “On the pharmaceuticals side 99% of our business from our Indian facilities is with Western companies​, We hope to create a similar customer base for the biologics business.”

Under that deal Kemwell agreed to provide tech transfer, process industrialization, scale-up, manufacturing of toxicology materials, cGMP manufacturing of clinical materials and commercial manufacturing for both drug substance and fill & finish in vials for the client.

The addition of freeze-drying technology has further expanded its fill finish offering.

Related news

Show more

Related products

show more

Baxter’s Oncology Contract Manufacturing

Baxter’s Oncology Contract Manufacturing

Baxter BioPharma Solutions | 29-Aug-2018 | Product Brochure

Baxter BioPharma Solutions’ FOYA award-winning facility in Halle/Westfalen, Germany, offers state-of-the-art parenteral cGMP manufacturing at one location,...

baxter_bloomington_facility_larger

Sterile Injectables Contract Manufacturing

Baxter BioPharma Solutions | 02-Apr-2018 | Product Brochure

Baxter BioPharma Solutions' award-winning facility in Bloomington, Indiana, USA, is a leader in sterile contract manufacturing of injectable products.

Leveraging Best Practices in Primary Packaging

Leveraging Best Practices in Primary Packaging

Catalent Pharma Solutions | 05-Mar-2018 | Technical / White Paper

When planning a clinical trial, overlooking the importance of primary packaging can be a mistake. From stability concerns to labeling to patient compliance...

Related suppliers

Follow us

Products

View more

Webinars